Evidence map›Paper›PMID 26586662›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2016

Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice.

Lena S Kiene, Susanne Homann, Tatsiana Suvorava, Berit Rabausch, Julia Müller, Georg Kojda, Inga Kretschmer, Sören Twarock, Guang Dai, René Deenen and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Hyaluronan in cardiac disease: implications for the extracellular matrix beyond collagen.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Hyaluronan biology: A complex balancing act of structure, function, location and context.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
  11. Cervical hyaluronan biology in pregnancy, parturition and preterm birth.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
  12. The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
  13. Article
  14. Article
  15. Knockout of hyaluronan synthase 1, but not 3, impairs formation of the retrocalcaneal bursa.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2018
    Article
  16. Hyaluronan synthase 3 promotes plaque inflammation and atheroprogression.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Article
  17. Article
  18. Provisional matrix: A role for versican and hyaluronan.Matrix biology : journal of the International Society for Matrix Biology · 2017
    Review
  19. Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGF-β1/SMAD and myocardin/serum response factor.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  20. Vascular Smooth Muscle Cells.Arteriosclerosis, thrombosis, and vascular biology · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 1 institution in 3 countries.

Lena S KieneInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Susanne HomannInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Tatsiana SuvoravaInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Berit RabauschInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Julia MüllerInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Georg KojdaInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Inga KretschmerInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Sören TwarockInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Guang DaiInstitut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
René DeenenBiologisch-Medizinisches Forschungszentrum (BMFZ), Universitätsklinikum der Heinrich-Heine- Universität Düsseldorf, Düsseldorf, Germany.
Sonja HartwigDeutsches Diabetes Zentrum, Düsseldorf, Germany.
Stefan LehrDeutsches Diabetes Zentrum, Düsseldorf, Germany.
Karl KöhrerBiologisch-Medizinisches Forschungszentrum (BMFZ), Universitätsklinikum der Heinrich-Heine- Universität Düsseldorf, Düsseldorf, Germany.
Rashmin C SavaniDivisions of Pulmonary & Vascular Biology and Neonatal-Perinatal Medicine, Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Maria Grandoch *Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Jens W Fischer *Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Düsseldorf University Hospital · DE

Funding

Pulmonary Collectins, Hyaluronan and MacrophagesR01HL073896 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SAVANI, RASHMIN C · 2004 to 2008
$1.7M
Hyaluronan in Lung Vascular DevelopmentR01HL075930 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SAVANI, RASHMIN C · 2003 to 2006
$1.6M
NHLBI NIH HHS HL073896NHLBI NIH HHS HL075930NHLBI NIH HHS R01 HL073896NHLBI NIH HHS R01 HL075930
6 · The paper itself

Abstract

objectiveHyaluronan (HA) is a polymeric glucosaminoglycan that forms a provisional extracellular matrix in diseased vessels. HA is synthesized by 3 different HA synthases (HAS1, HAS2, and HAS3). Aim of this study was to unravel the role of the HAS3 isoenzyme during experimental neointimal hyperplasia. APPROACH AND

resultsNeointimal hyperplasia was induced in Has3-deficient mice by ligation of the carotid artery. HA in the media of Has3-deficient mice was decreased 28 days after ligation, and neointimal hyperplasia was strongly inhibited. However, medial and luminal areas were unaffected. Cell density, proliferation, and apoptosis were not altered, suggesting a proportional decrease of both, the number of cells and extracellular matrix. In addition, endothelial function as determined by acetylcholine-induced relaxation of aortic rings, immunoblotting of endothelial nitric oxide synthase, and arterial blood pressure were not affected. Furthermore, the oxidative stress response was not affected as determined in total protein extracts from aortae. Transcriptome analysis comparing control versus ligated carotid arteries hinted toward a mitigated differential regulation of various signaling pathways in Has3-deficient mice in response to ligation that were related to vascular smooth muscle cell (VSMC) migration, including focal adhesions, integrins, mitogen-activated protein kinase, and phosphatidylinositol signaling system. Lentiviral overexpression of HAS3 in VSMC supported the migratory phenotype of VSMC in response to platelet-derived growth factor BB in vitro. Accordingly, knockdown of HAS3 reduced the migratory response to platelet-derived growth factor BB and in addition decreased the expression of PDGF-B mRNA.

conclusionsHAS3-mediated HA synthesis after vessel injury supports seminal signaling pathways in activation of VSMC, increases platelet-derived growth factor BB-mediated migration, and in turn enhances neointimal hyperplasia in vivo.

Indexed as

NeointimaAnimalsBecaplerminCarotid Artery, CommonCarotid Artery DiseasesCell MovementCell ProliferationCells, CulturedExtracellular MatrixFemaleGene DeletionGene Expression RegulationGenotypeGlucuronosyltransferaseHyaluronan SynthasesMice, 129 StrainBecaplerminGlucuronosyltransferaseHas3 protein, mouseHyaluronan SynthasesProto-Oncogene Proteins c-siscarotid arteriesextracellular matrixhyaluronanneointimasmooth muscle cells

Identifiers

PMID26586662
PMCPMC5222548
OpenAlexW2266171724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.